AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 26691637 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in HRV
Number of subjects: 282
Study 24518763 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound guided transversus abdominis plane block
Number of subjects: 32
Study 24518763 — intervention group
Group type: COMPARATOR
Intervention: Surgeon administered regional field infiltration with bupivacaine
Number of subjects: 32
Study 22338626 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic yogurt (200 g/day)
Number of subjects: 70
Study 22338626 — intervention group
Group type: COMPARATOR
Intervention: Conventional yogurt (200 g/day)
Number of subjects: 70
Study 19416560 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive‐behavioural minimal contact bibliotherapy, delivered via the book 'Doctor, I Hope it's Nothing Serious?', containing cognitive behavioural theory and exercises.
Number of subjects: 0
Study 19416560 — intervention group
Group type: COMPARATOR
Intervention: Waiting list condition (control group)
Number of subjects: 0
Study 17627016 — intervention group
Group type: EXPERIMENTAL
Intervention: High tertile of total serum IgE
Number of subjects: 467
Study 17627016 — intervention group
Group type: EXPERIMENTAL
Intervention: Middle tertile of total serum IgE
Number of subjects: 467
Study 17627016 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific IgE to common aeroallergens (defined as >or=0.35 kU/L)
Number of subjects: 467
Study 17627016 — intervention group
Group type: EXPERIMENTAL
Intervention: Total serum IgE levels before treatment
Number of subjects: 467
Study 17627016 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean levels of all immunoglobulins (IgA, IgM, IgG)
Number of subjects: 467
Study 15899724 — intervention group
Group type: EXPERIMENTAL
Intervention: rosiglitazone 4 mg/day
Number of subjects: 95
Study 15899724 — intervention group
Group type: COMPARATOR
Intervention: glimepiride 2 mg/day
Number of subjects: 95
Study 12032397 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg/day
Number of subjects: 22
Study 12032397 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 9650373 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin E2 gel (0.5 mg administered intracervically)
Number of subjects: 247
Study 9650373 — intervention group
Group type: EXPERIMENTAL
Intervention: Dilapan S rods (four hygroscopic rods applied intracervically)
Number of subjects: 247
Study 9650373 — intervention group
Group type: EXPERIMENTAL
Intervention: Estradiol gel (150 mg administered intravaginally)
Number of subjects: 247
Study 9506204 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (IVIG) therapy
Number of subjects: 0
Study 9506204 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 1850128 — intervention group
Group type: EXPERIMENTAL
Intervention: High fat-low fiber diet (96 g fat/day, 6 g fiber/day)
Number of subjects: 43
Study 1850128 — intervention group
Group type: COMPARATOR
Intervention: Low fat-high fiber diet (33 g fat/day, 41 g fiber/day)
Number of subjects: 43
Study 7039667 — intervention group
Group type: EXPERIMENTAL
Intervention: Adrenaline 1% combined with guanethidine 1%
Number of subjects: 20
Study 7039667 — intervention group
Group type: COMPARATOR
Intervention: Adrenaline 1%
Number of subjects: 20
Study 30903306 — intervention group
Group type: EXPERIMENTAL
Intervention: iGEL
Number of subjects: 116
Study 30903306 — intervention group
Group type: EXPERIMENTAL
Intervention: Air‐Q intubating laryngeal airway
Number of subjects: 116
Study 30903306 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambu AuraGain disposable laryngeal mask
Number of subjects: 116
Study 27370941 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol 1g IV
Number of subjects: 100
Study 27370941 — intervention group
Group type: COMPARATOR
Intervention: Ketorolac 30mg IV
Number of subjects: 100
Study 25342708 — intervention group
Group type: EXPERIMENTAL
Intervention: AG2 (bed rest and six periods of 5 min AG daily)
Number of subjects: 11
Study 25342708 — intervention group
Group type: EXPERIMENTAL
Intervention: AG1 (bed rest and 30 min of AG daily)
Number of subjects: 11
Study 25342708 — intervention group
Group type: COMPARATOR
Intervention: Control (bed rest without countermeasures)
Number of subjects: 11
Study 25342708 — intervention group
Group type: EXPERIMENTAL
Intervention: AG1 and AG2
Number of subjects: 11
Study 25524951 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood 25-hydroxyvitamin D concentration <50 nmol/L
Number of subjects: 0
Study 25524951 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood 25-hydroxyvitamin D concentration
Number of subjects: 0
Study 23474735 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive virtual telerehabilitation system
Number of subjects: 142
Study 23474735 — intervention group
Group type: COMPARATOR
Intervention: Conventional out-patient physical therapy
Number of subjects: 142
Study 21741446 — intervention group
Group type: EXPERIMENTAL
Intervention: Fuzhisan (FZS, 10mg/day)
Number of subjects: 22
Study 21741446 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 19028407 — intervention group
Group type: EXPERIMENTAL
Intervention: Alefacept plus MTX
Number of subjects: 160
Study 19028407 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus MTX
Number of subjects: 160
Study 16779510 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryosurgery
Number of subjects: 40
Study 16779510 — intervention group
Group type: COMPARATOR
Intervention: Conventional stripping
Number of subjects: 40
Study 16779510 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryosurgery and Conventional stripping
Number of subjects: 40
Study 14757693 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiopulmonary bypass (CPB)
Number of subjects: 300
Study 14757693 — intervention group
Group type: COMPARATOR
Intervention: Beating heart surgery
Number of subjects: 300
Study 11783697 — intervention group
Group type: EXPERIMENTAL
Intervention: ceftazidime 2 g t.i.d. (n=12)
Number of subjects: 27
Study 11783697 — intervention group
Group type: COMPARATOR
Intervention: imipenem/cilastatin 1 g t.i.d. (n=15)
Number of subjects: 27
Study 11783697 — intervention group
Group type: EXPERIMENTAL
Intervention: Both ceftazidime and imipenem
Number of subjects: 27
Study 10102907 — intervention group
Group type: EXPERIMENTAL
Intervention: Near-patient CRP test using NycoCard(R) CRP
Number of subjects: 1853
Study 10102907 — intervention group
Group type: COMPARATOR
Intervention: Control group (mailing blood samples for CRP measurements)
Number of subjects: 1853
Study 7521815 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 0
Study 7521815 — intervention group
Group type: COMPARATOR
Intervention: Best supportive care
Number of subjects: 0
Study 2527732 — intervention group
Group type: EXPERIMENTAL
Intervention: Procaterol 100 micrograms
Number of subjects: 6
Study 2527732 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 594790 — intervention group
Group type: EXPERIMENTAL
Intervention: Diethylstilbestrol (DES, 5 mg/day)
Number of subjects: 0
Study 594790 — intervention group
Group type: EXPERIMENTAL
Intervention: Orchiectomy plus DES
Number of subjects: 0
Study 594790 — intervention group
Group type: EXPERIMENTAL
Intervention: Orchiectomy plus placebo
Number of subjects: 0
Study 594790 — intervention group
Group type: EXPERIMENTAL
Intervention: Orchiectomy alone
Number of subjects: 0
Study 594790 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31238372 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine lactoferrin (BLF)
Number of subjects: 472
Study 31238372 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 472
Study 27804203 — intervention group
Group type: EXPERIMENTAL
Intervention: Wake therapy
Number of subjects: 13
Study 27804203 — intervention group
Group type: EXPERIMENTAL
Intervention: Light therapy (30 min daily for 9 weeks)
Number of subjects: 13
Study 27804203 — intervention group
Group type: EXPERIMENTAL
Intervention: Ongoing psychoeducation regarding good sleep hygiene
Number of subjects: 13
Study 27804203 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall treatment experience
Number of subjects: 13
Study 27804203 — intervention group
Group type: EXPERIMENTAL
Intervention: Social support
Number of subjects: 13
Study 26011718 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental skills training
Number of subjects: 2432
Study 26011718 — intervention group
Group type: COMPARATOR
Intervention: Military history (control)
Number of subjects: 2432
Study 22527135 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise combined with TENS for the first 3 weeks
Number of subjects: 66
Study 22527135 — intervention group
Group type: COMPARATOR
Intervention: Supervised exercise without TENS
Number of subjects: 66
Study 22527135 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Supervised exercise with and without TENS)
Number of subjects: 66
Study 21359522 — intervention group
Group type: EXPERIMENTAL
Intervention: Rabeprazole (20 mg) plus rebamipide (300 mg)
Number of subjects: 0
Study 21359522 — intervention group
Group type: COMPARATOR
Intervention: Rabeprazole (20 mg)
Number of subjects: 0
Study 19843657 — intervention group
Group type: EXPERIMENTAL
Intervention: Lu 35‐138 (I(Kr)‐blocking antipsychotic compound)
Number of subjects: 79
Study 19843657 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79
Study 19843657 — intervention group
Group type: EXPERIMENTAL
Intervention: Lu 35‐138
Number of subjects: 79
Study 19843657 — intervention group
Group type: EXPERIMENTAL
Intervention: MCS as a covariate
Number of subjects: 79
Study 16389665 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric exercise (5 minutes)
Number of subjects: 60
Study 16389665 — intervention group
Group type: COMPARATOR
Intervention: Body scanning (control)
Number of subjects: 60
Study 16389665 — intervention group
Group type: COMPARATOR
Intervention: Sitting passively (control)
Number of subjects: 60
Study 15214594 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFOX regimen (oxaliplatin, infusional 5-FU, leucovorin)
Number of subjects: 0
Study 15214594 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative 5-FU-based chemotherapy combined with irradiation
Number of subjects: 0
Study 15214594 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative combined-modality therapy
Number of subjects: 0
Study 15214594 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral capecitabine (Xeloda) as a radiation enhancer
Number of subjects: 0
Study 15214594 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFOX and FOLFIRI regimens
Number of subjects: 0
Study 11426361 — intervention group
Group type: EXPERIMENTAL
Intervention: HES 130/0.4
Number of subjects: 42
Study 11426361 — intervention group
Group type: COMPARATOR
Intervention: Gelatin
Number of subjects: 42
Study 9105077 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory elastic load of 18 cm H2O/L
Number of subjects: 11
Study 10451950 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefodizime
Number of subjects: 107
Study 10451950 — intervention group
Group type: COMPARATOR
Intervention: Ceftizoxime
Number of subjects: 107
Study 2630295 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 mg of caffeine
Number of subjects: 40
Study 2630295 — intervention group
Group type: COMPARATOR
Intervention: Placebo (3 mg) in decaffeinated coffee
Number of subjects: 40
Study 235013 — intervention group
Group type: EXPERIMENTAL
Intervention: Pimozide (mean 18.8 mg/day for 6 weeks)
Number of subjects: 18
Study 31167457 — intervention group
Group type: EXPERIMENTAL
Intervention: Game Over Intervention (GOI)
Number of subjects: 362
Study 31167457 — intervention group
Group type: COMPARATOR
Intervention: Control condition (effective learning program)
Number of subjects: 362
Study 28950297 — intervention group
Group type: EXPERIMENTAL
Intervention: CRLX101 + bevacizumab
Number of subjects: 111
Study 28950297 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 111
Study 25228137 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivermectin 1% cream (IVM 1%) once daily
Number of subjects: 962
Study 25228137 — intervention group
Group type: COMPARATOR
Intervention: Metronidazole 0.75% cream (MTZ 0.75%) twice daily
Number of subjects: 962
Study 23319069 — intervention group
Group type: EXPERIMENTAL
Intervention: Printed decision support intervention
Number of subjects: 33
Study 23319069 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-assisted decision support intervention
Number of subjects: 33
Study 23319069 — intervention group
Group type: COMPARATOR
Intervention: Control sites
Number of subjects: 33
Study 21531671 — intervention group
Group type: EXPERIMENTAL
Intervention: Actual Reiki therapy
Number of subjects: 189
Study 21531671 — intervention group
Group type: COMPARATOR
Intervention: Sham Reiki placebo
Number of subjects: 189
Study 21531671 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 189
Study 19750999 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic radiation therapy (700 cGy)
Number of subjects: 0
Study 19750999 — intervention group
Group type: COMPARATOR
Intervention: Control group (no radiation therapy)
Number of subjects: 0
Study 16984677 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive intervention (counseling and support for mother-infant relationship)
Number of subjects: 151
Study 16984677 — intervention group
Group type: COMPARATOR
Intervention: Routine primary care (control)
Number of subjects: 151
Study 16984677 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive intervention
Number of subjects: 151
Study 15607618 — intervention group
Group type: EXPERIMENTAL
Intervention: cerivastatin (0.3 mg/day)
Number of subjects: 24
Study 15607618 — intervention group
Group type: EXPERIMENTAL
Intervention: candesartan (8 mg/day)
Number of subjects: 24
Study 15607618 — intervention group
Group type: COMPARATOR
Intervention: Control group (24 normocholesterolemic subjects without any therapy)
Number of subjects: 24
Study 11282864 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant drugs
Number of subjects: 323
Study 11282864 — intervention group
Group type: EXPERIMENTAL
Intervention: Generic counselling
Number of subjects: 323
Study 11282864 — intervention group
Group type: COMPARATOR
Intervention: Randomised arms (both interventions)
Number of subjects: 323
Study 11282864 — intervention group
Group type: COMPARATOR
Intervention: Overall assessment by psychiatrist
Number of subjects: 323
Study 11282864 — intervention group
Group type: COMPARATOR
Intervention: Overall remission
Number of subjects: 323
Study 11282864 — intervention group
Group type: COMPARATOR
Intervention: Relapse
Number of subjects: 323
Study 9291700 — intervention group
Group type: EXPERIMENTAL
Intervention: Family caregivers' assessments of patients' symptom distress
Number of subjects: 37
Study 9291700 — intervention group
Group type: COMPARATOR
Intervention: Patients' self-reports of symptom distress
Number of subjects: 37
Study 8445152 — intervention group
Group type: COMPARATOR
Intervention: 50 mU biosynthetic human growth hormone (r‐hGH) bolus
Number of subjects: 11
Study 8445152 — intervention group
Group type: COMPARATOR
Intervention: 80 mU/h iv infusion of r‐hGH
Number of subjects: 11
Study 8445152 — intervention group
Group type: COMPARATOR
Intervention: 500 mU r‐hGH bolus
Number of subjects: 11
Study 8445152 — intervention group
Group type: EXPERIMENTAL
Intervention: GHRH (1‐29) NH2 (100 micrograms)
Number of subjects: 11
Study 3813608 — intervention group
Group type: EXPERIMENTAL
Intervention: 2000 IU vitamin D supplementation
Number of subjects: 49
Study 3813608 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 IU vitamin D supplementation
Number of subjects: 49
Study 3813608 — intervention group
Group type: COMPARATOR
Intervention: No vitamin D supplementation (control group 3)
Number of subjects: 49
Study 3813608 — intervention group
Group type: COMPARATOR
Intervention: 400 IU vitamin D supplementation for infants
Number of subjects: 49
Study 3813608 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal supplementation with 2000 IU of vitamin D
Number of subjects: 49
Study 3813608 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal supplementation with 1000 IU of vitamin D
Number of subjects: 49
Study 29308949 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobilization with movements (MWMs)
Number of subjects: 72
Study 29308949 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive joint mobilization (PJM)
Number of subjects: 72
Study 29308949 — intervention group
Group type: COMPARATOR
Intervention: Electrotherapy
Number of subjects: 72
Study 26674087 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management group intervention
Number of subjects: 24
Study 26674087 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 24
Study 24419019 — intervention group
Group type: EXPERIMENTAL
Intervention: Electromyography-triggered neuromuscular stimulation and mirror therapy (ETMS-MT)
Number of subjects: 13
Study 24419019 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed ETMS-MT
Number of subjects: 13
Study 22404531 — intervention group
Group type: EXPERIMENTAL
Intervention: Suprapubic cystostomy
Number of subjects: 65
Study 22404531 — intervention group
Group type: COMPARATOR
Intervention: Urethral Foley catheter
Number of subjects: 65
Study 20495788 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute tyrosine and phenylalanine depletion (ATPD)
Number of subjects: 29
Study 20495788 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 18562328 — intervention group
Group type: EXPERIMENTAL
Intervention: Anthracycline-docetaxel-based sequential or concurrent chemotherapy
Number of subjects: 2887
Study 18562328 — intervention group
Group type: COMPARATOR
Intervention: Anthracycline-based adjuvant chemotherapy
Number of subjects: 2887
Study 18562328 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel-treated patients
Number of subjects: 2887
Study 15650663 — intervention group
Group type: EXPERIMENTAL
Intervention: TransFix cross‐pin fixation
Number of subjects: 62
Study 15650663 — intervention group
Group type: COMPARATOR
Intervention: Metal interference screw fixation
Number of subjects: 62
Study 12437859 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced care patients received bimonthly protective treatment and twice-daily chlorhexidine mouthrinses to treat gingivitis
Number of subjects: 376
Study 12437859 — intervention group
Group type: COMPARATOR
Intervention: Control group subjects received professional dental protective treatment and checkups at baseline, 6 months, and 1 year, plus dental care
Number of subjects: 376
Study 10851564 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose fosinopril (10 mg/d)
Number of subjects: 0
Study 10851564 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 7502497 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy
Number of subjects: 47
Study 7502497 — intervention group
Group type: COMPARATOR
Intervention: Open cholecystectomy
Number of subjects: 47
Study 1952007 — intervention group
Group type: EXPERIMENTAL
Intervention: Neostigmine 15 micrograms/kg with glycopyrronium 3 micrograms/kg
Number of subjects: 32
Study 1952007 — intervention group
Group type: EXPERIMENTAL
Intervention: Neostigmine 35 micrograms/kg with glycopyrronium 7 micrograms/kg
Number of subjects: 32
Study 1952007 — intervention group
Group type: EXPERIMENTAL
Intervention: Neostigmine 55 micrograms/kg with glycopyrronium 11 micrograms/kg
Number of subjects: 32
Study 1952007 — intervention group
Group type: EXPERIMENTAL
Intervention: Neostigmine 75 micrograms/kg with glycopyrronium 15 micrograms/kg
Number of subjects: 32
Study 6316711 — intervention group
Group type: EXPERIMENTAL
Intervention: Ventilation tubes
Number of subjects: 150
Study 6316711 — intervention group
Group type: COMPARATOR
Intervention: Intact ears (control)
Number of subjects: 150
Study 6316711 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with initial tonsillectomy
Number of subjects: 150
Study 29788243 — intervention group
Group type: EXPERIMENTAL
Intervention: Social support (measured with the Multidimensional Scale of Perceived Social Support)
Number of subjects: 3496
Study 29788243 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifetime and past year victimization
Number of subjects: 3496
Study 28461283 — intervention group
Group type: EXPERIMENTAL
Intervention: HERA (Health Evaluation and Referral Assistant)
Number of subjects: 212
Study 28461283 — intervention group
Group type: EXPERIMENTAL
Intervention: HERA (Health Evaluation and Referral Assistant) with faxed referral
Number of subjects: 212
Study 28461283 — intervention group
Group type: COMPARATOR
Intervention: Minimal-treatment control
Number of subjects: 212
Study 26691925 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer feedback (PF)
Number of subjects: 24
Study 26691925 — intervention group
Group type: COMPARATOR
Intervention: Faculty feedback (FF)
Number of subjects: 24
Study 25059927 — intervention group
Group type: EXPERIMENTAL
Intervention: AIS-GIB score (18-point scoring system based on independent predictors of GIB)
Number of subjects: 8820
Study 22019112 — intervention group
Group type: EXPERIMENTAL
Intervention: Home blood pressure monitoring (HBPM) program
Number of subjects: 232
Study 22019112 — intervention group
Group type: COMPARATOR
Intervention: Standard health intervention (Control group)
Number of subjects: 232
Study 19290714 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-month expert system intervention (SunSmart)
Number of subjects: 819
Study 19290714 — intervention group
Group type: COMPARATOR
Intervention: Physical activity and nutrition comparison group
Number of subjects: 819
Study 17360294 — intervention group
Group type: EXPERIMENTAL
Intervention: Clanging Tuning Fork (CTF) test
Number of subjects: 45
Study 17360294 — intervention group
Group type: COMPARATOR
Intervention: 10-g Semmes-Weinstein monofilament test
Number of subjects: 45
Study 15347374 — intervention group
Group type: EXPERIMENTAL
Intervention: Injective immunotherapy with a maintenance dose of 7.2 microg of Amb a 1 administered at 4-week intervals
Number of subjects: 32
Study 15347374 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 11837227 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet enriched in saturated fatty acids (SFA)
Number of subjects: 59
Study 11837227 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet enriched in carbohydrates (NCEP‐1)
Number of subjects: 59
Study 11837227 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet enriched in monounsaturated fatty acids (MUFA)
Number of subjects: 59
Study 11837227 — intervention group
Group type: EXPERIMENTAL
Intervention: Saturated diet to either of the other diets (carbohydrates or MUFA)
Number of subjects: 59